<DOC>
	<DOC>NCT01169805</DOC>
	<brief_summary>The aim of this prospective randomized controlled study was to compare the prophylactic effects of intravenous single dose of ondansetron, ramosetron, and palonosetron on PCA-related nausea and vomiting after urologic laparoscopic surgery.</brief_summary>
	<brief_title>Prophylactic Effects of Ondansetron, Ramosetron, and Palonosetron on Patient-Controlled Analgesia Related Nausea and Vomiting After Urologic Laparoscopic Surgery</brief_title>
	<detailed_description />
	<mesh_term>Vomiting</mesh_term>
	<mesh_term>Palonosetron</mesh_term>
	<mesh_term>Ramosetron</mesh_term>
	<mesh_term>Ondansetron</mesh_term>
	<criteria>ASA I or II Patients aged (2065 yr) Undergoing Laparoscopic Nephrectomy Patients who want a patientcontrolled IV analgesia (IVPCA) History of allergy or hypersensitivity to 5HT3 antagonist History of severe postoperative nausea/vomiting Prolonged QT interval on preoperative EKG Hypokalemia, Hypomagnesemia Intestinal obstruction Pregnant female or breast feeding mother</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2011</verification_date>
</DOC>